Browsing publications by Professor James Allan

Newcastle AuthorsTitleYearFull text
Professor James Allan
Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism2016
Dr Victoria Forster
Mohammed Nahari
Dr Natalia Martinez Soria
Amy Bradburn
Dr Sarah Fordham
et al.
The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype2016
Professor James Allan
Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease2016
Dr Mark Wade
Dr Nicola Sunter
Dr Sarah Fordham
Anna Long
Dino Mašić
et al.
c-MYC is a radiosensitive locus in human breast cells2015
Professor James Allan
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis2015
Fiona Middleton
Dr Miranda Patterson
Dr Claire Elstob
Dr Sarah Fordham
Dr Ashleigh Herriott
et al.
Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition2015
Dr Nicola Sunter
Dr Helen Marr
Professor Andy Hall
Dr Tryfonia Mainou-Fowler
Professor Graham Jackson
et al.
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk2015
Dr Sarah Fordham
Mike Cole
Dr Julie Irving
Professor James Allan
Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia2015
Dr Julie Irving
Elizabeth Matheson
Helen Blair
Marian Case
Isabella Swidenbank
et al.
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-34302015
Dr Helen Marr
Dr Luke Gaughan
Dr Susan Tudhope
Professor James Allan
Regulation of CD38 in IRF4 in Chronic Lymphocytic Leukaemia2015
1234567